510(k) K033982
K033982 is an FDA 510(k) premarket notification submitted by Vysis for the device "MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST". The FDA issued a decision of Substantially Equivalent on Jan 22, 2004. The device falls under product code MMW (System, Test, Tumor Marker, Monitoring, Bladder), a Class II device regulated under 21 CFR 866.6010. Vysis has 8 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Jan 22, 2004
- Date Received
- Dec 23, 2003
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Tumor Marker, Monitoring, Bladder
- Device Class
- Class II
- Regulation Number
- 866.6010
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Vysis? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.